Longeveron Inc. Common Stock
Veridion Score
Composite trend over time
Why is LGVN moving today?
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for LGVN.
LGVN insider activity
Longeveron Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Net selling: -$228K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 | 2026-07-01 | Locklear Lisa | Insider | sell | $0.73 | 22,505 | 443,181 | $16K | SEC Form 4 |
| 2026-07-06 | 2026-07-01 | Agafonova Nataliya | Insider | sell | $0.73 | 22,505 | 430,914 | $16K | SEC Form 4 |
| 2026-07-06 | 2026-07-01 | Blass Devin | Insider | sell | $0.73 | 15,808 | 425,735 | $12K | SEC Form 4 |
| 2026-07-06 | 2026-07-01 | Lehr Paul T | Insider | sell | $0.73 | 13,143 | 575,423 | $10K | SEC Form 4 |
| 2026-07-06 | 2026-07-01 | Willard Stephen H | Insider | sell | $0.73 | 18,046 | 771,681 | $13K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 16 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moLGVN contract awards, year to date.
Public federal awards linked to this ticker.
LGVN lobbying filings, year to date.
Registered lobbying filings matched to Longeveron Inc. Common Stock.